Accéder au contenu
Merck
  • Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.

Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.

FEBS letters (2015-06-23)
Rika Nishikawa, Takeshi Chiyomaru, Hideki Enokida, Satoru Inoguchi, Tomoaki Ishihara, Ryosuke Matsushita, Yusuke Goto, Ichiro Fukumoto, Masayuki Nakagawa, Naohiko Seki
RÉSUMÉ

Here, we found that members of the microRNA-29 family (miR-29a/b/c; "miR-29s") were significantly reduced in clear cell renal cell carcinoma (ccRCC) tissues, suggesting that they functioned as tumour suppressors. Restoration of all mature members of the miR-29 family inhibited cancer cell proliferation, migration and invasion. LOXL2 was a direct target gene of miR-29s, as shown by genome-wide gene expression analysis and luciferase reporter assay. Overexpressed LOXL2 was confirmed in ccRCC clinical specimens, and silencing of LOXL2 inhibited cancer cell migration and invasion in ccRCC cell lines. Our data demonstrated that the miR-29s-LOXL2 axis contributed to cancer cell migration and invasion in ccRCC.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Lysyl Oxidase-like 2 (LOXL2) FLAG-tag (Sf9-derived) human, recombinant, expressed in baculovirus infected insect cells, ≥65% (SDS-PAGE)